- One systematic review was identified that met the inclusion and exclusion criteria
- Varying doses of corticosteroids used in the treatment of admitted patients with acute asthma appear to result in similar outcomes when pulmonary function data are examined.
- Higher doses of corticosteroids do not appear to have an obvious therapeutic advantage for severe asthma patients
- The results may not be generalisable to COPD patients, mild asthmatics, or patients with ventilatory support.
- We are unable to determine the effect of differing doses of corticosteroids on time to discharge, adverse events or quality of life.
- We are unable to reach conclusions regarding the dosing effect for intravenous and oral corticosteroids individually.